Substantia innominata: MR findings in Parkinson's disease

Neuroradiology

Volumn 46, Issue 10, 2004, Pages 817-821

  Oikawa, Hirobumi ^a   Sasaki, Makoto ^a   Ehara, Shigeru ^a   Abe, Takashi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Mini mental status examination; Nucleus basalis of Meynert; Parkinson's disease; Substantia innominata

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUBSTANTIA INNOMINATA;

ADULT; AGED; CASE-CONTROL STUDIES; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SUBSTANTIA INNOMINATA;

EID: 8844244020     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1257-4     Document Type: Article

References (21)

1. Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson's disease. Ann Neurol 13:243-248 1:STN:280:BiyB3c3ntl0%3D, 6847136
2. Sasaki M, Ehara S, Tamakawa Y et al (1995) MR anatomy of the substantia innominata and findings in Alzheimer disease; A preliminary report. Am J Neuroradiol 16:2001-2007 1:STN:280:BymC2MbhsFQ%3D, 8585486
3. Hanyu H, Tanaka Y, Sakurai H, Takasaki M, Abe K (2002) Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease. Neurosci Lett 319:33-36 10.1016/S0304-3940(01)02507-1, 1:CAS:528:DC%2BD38Xos1ymuw%3D%3D, 11814647
4. Hanyu H, Asano T, Sakurai H et al (2002) MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. Am J Neuroradiol 23:27-32 11827872
5. Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson's disease. Ann Neurol 32:S125-127 1510370
6. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer's disease; evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126 1:STN:280:Bi2D383ivFw%3D, 7283399
7. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1234-1237
8. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313-330 1:STN:280:Bi2B3cjntlE%3D, 7082992
9. White P, Hiley CR, Goodhardt MJ et al (1977) Neocortical cholinergic neurons in elderly people. Lancet I:668-671 10.1016/S0140-6736(77)92114-6
10. Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II: 1403 10.1016/S0140-6736(76)91936-X
11. Whitehouse PJ (1986) Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. Adv Neurol 45:393-397
12. Loranger AW, Goodell H, McDowell FH et al (1972) Intellectual impairment in Parkinson's syndrome. Brain 95:405-412 1:STN:280:CSyC3s7htVU%3D, 4655035
13. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer's disease: A role for extranigral factors? Arch Neurol 46:651-657 1:STN:280:BiaB2s3ntFM%3D, 2730377
14. Bruno D, Merle R, France JA, Alain P, Yves A (1983) A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288:213-218 10.1016/0006-8993(83)90096-3, 6661617
15. Hirano A, Zimmerman HM (1962) Alzheimer's neurofibrillary changes. Arch Neurol 7:227-242 1:STN:280:CC2D2cfpvFI%3D, 13907611
16. Steven JH, Edwin CS, Jeffrey AC, Donald WC, Andrew C, George WP (1989) Magnetic resonance imaging in dementia of Parkinson's disease. J Neurol Neurosurg Psychiatry 52:1221-1227 2592966
17. Lichter DG, Corbett AJ, Fitzgibbon GM et al (1988) Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance and computed tomographic correlations. Arch Neurol 45:854-860 1:STN:280:BieB1c%2Fmt1U%3D, 3293555
18. Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetization transfer measurement of the subcortical gray and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43:542-546 10.1007/s002340100558, 1:STN:280:DC%2BD3MvmslOltQ%3D%3D, 11512582
19. Carpenter MB, Sutin J (1991) Human neuroanatomy, 4th edn. Williams and Wilkins, Baltimore, pp 382-384
20. Mesulam MM, Mufson EJ, Levey AI et al (1983) Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170-197 1:STN:280:BiyC1cnpt1c%3D, 6841683
21. Mesulam MM, Van Hoesen GW (1976) Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res 109:152-157 10.1016/0006-8993(76)90385-1, 1:STN:280:CSmB3cjmt10%3D, 819100